| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 12/20/2006 | EP0966442B1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
| 12/20/2006 | CN1882587A Use of tricyclic compounds as glycine transport inhibitors |
| 12/20/2006 | CN1882586A 1H-imidazo[4,5-C]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 12/20/2006 | CN1882585A Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 12/20/2006 | CN1882565A Novel piperidine-substituted indoles-or hetero-derivatives thereof and their use as modulators of chemokine receptor (CCR-3) |
| 12/20/2006 | CN1882564A Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 12/20/2006 | CN1880319A Tropane derivatives as CCR5 modulators |
| 12/20/2006 | CN1880314A Synthesis method of red doped material BDCJT for OLED device |
| 12/20/2006 | CN1880313A Novel heterocycle naphthoylimine and double-chain compound and its uses in tumour cell |
| 12/20/2006 | CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 12/20/2006 | CN1290847C Aza-arylpiperazines |
| 12/20/2006 | CN1290846C Pyrazolo[1,5-a]pyridines and medicaments containing thereof |
| 12/19/2006 | US7151174 Selective oxidation of the the N-atom of the quinoline group using a peroxomonosulfuric acid, peroxodisulfuric acid or their salts in the presence of a ketone; N-atoms of the 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one scaffold are not oxidized |
| 12/19/2006 | US7151110 4-Methoxy-6-[3-(6-methyl-pyridin-2-yl)-1H-pyrazol-4-yl]-quinoline; inhibits the TGF-beta signaling pathway; anticancer, antifibrotic, antitumor, and antiproliferative agents |
| 12/19/2006 | US7151109 Psychological disorders; anxiolytic agents; antidepressants |
| 12/19/2006 | US7151108 Anticarcinogenic, antiproliferative, and antitumor agents |
| 12/19/2006 | US7151104 Pyrazolopyridines as cyclin dependent kinase inhibitors |
| 12/19/2006 | US7151097 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 12/19/2006 | US7151096 For therapy and prophylaxis of diseases and disorders associated with cyclin-dependent kinases (CDKs) activity |
| 12/19/2006 | CA2259538C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 12/19/2006 | CA2168659C Substituted azaindolylidene compounds and process for their preparation |
| 12/14/2006 | WO2006132197A1 HETEROCYCLIC COMPOUND HAVING TYPE I 11β HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY |
| 12/14/2006 | WO2006131835A2 Heterocyclic triazines as hypoxic selective protein kinase inhibitors |
| 12/14/2006 | WO2006072636A3 1, 5, 6-substituted-2-oxo-3-cyano-1, 6a-diaza-tetrahydro-fluoranthenes as anti-infective agents |
| 12/14/2006 | US20060281924 Fluorinated dyes or colorants and their uses |
| 12/14/2006 | US20060281922 1,4,5,8-naphthalene diimide (ND) imidazole derivatives, which are coordinatively attached to an electrochemiluminescent Ru(bpy)22+ ; detecting a double strand nucleic acid molecule using above threading intercalator |
| 12/14/2006 | US20060281784 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 12/14/2006 | US20060281782 Method for the enantioselective preparation of sulphoxide derivatives |
| 12/14/2006 | US20060281779 1 -cyclopropyl-7- [3-cyclopropylaminomethyl-4-fluoro-1 -pyrrolidinyl]-6-fluoro -1 ,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic acid; bactericide; against drug-resistant bacteria and against gram-positive bacteria, such as MRSA, PRSP and VRE |
| 12/14/2006 | US20060281777 Process for preparing crystalline form I of cabergoline |
| 12/14/2006 | US20060281776 Isotope labeled camptothecin derivatives |
| 12/14/2006 | US20060281750 3-Cycloheptyl-8-((2,6-dichlorophenoxy)methyl)H-imidazo[1,5-a]pyridine; N-((3-((2,6-Dichlorophenoxy)methyl)pyridin-2-yl)methyl)cycloheptane-carboxamide; diabetes; cardiovascular diseases, Metabolic Syndrome, inflammatory diseases |
| 12/14/2006 | US20060281746 neurokinin receptor 3 (NK3) antagonists; psychological disorders, inflammatory bowel disease, asthma, ischemia, Parkinson's disease; e.g. (1S,2R)-2-(4-Acetylamino-4-phenyl-piperidin-1-ylmethyl)-1-(3,4-dichlorophenyl)-cyclopropanecarboxylic acid, benzyl-methyl-amide |
| 12/14/2006 | US20060281733 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring |
| 12/14/2006 | US20060281725 Agents and crystals for improving excretory potency of urinary bladder |
| 12/14/2006 | US20060281146 Novel compositions and methods for the treatment of immune related diseases |
| 12/14/2006 | US20060280692 A condensation aerosol for delivery of olanzapine by heating a compositionof olanzapine coated on a solid support to vaporize and condense; the vapor comprising particles of >10 percent by weight of olanzapine and <5 percent by weight of olanzapine degradation products; aerodynamic diameter=<5 microns |
| 12/14/2006 | DE102005027169A1 Tetrahydrochinolinderivate Tetrahydroquinoline |
| 12/14/2006 | DE102005027168A1 Tetrahydrochinoline Tetrahydroquinolines |
| 12/14/2006 | CA2611312A1 Organic compounds |
| 12/13/2006 | EP1730149A1 Novel naphthalene derivatives and coloring agents containing these compounds, for keratin fibers |
| 12/13/2006 | EP1730147A1 Substituted 1,4,8-triazaspiro[4,5]decan-2-on compounds for use in the treatment of obesity |
| 12/13/2006 | EP1730146A1 Azaindoles useful as inhibitors of jak and other protein kinases |
| 12/13/2006 | EP1730145A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics |
| 12/13/2006 | EP1730144A1 Substituted 1,4,8-triazaspiro¬4.5|decan-2-one compounds |
| 12/13/2006 | EP1730143A2 Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| 12/13/2006 | EP1730119A1 Imidazole compounds for the treatment of neurodegenerative disorders |
| 12/13/2006 | EP1730114A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders |
| 12/13/2006 | EP1729777A1 Pharmaceutical composition comprising a salt of mirtazapine |
| 12/13/2006 | EP1729763A2 Novel bicyclic compounds as modulators of androgen receptor function and method |
| 12/13/2006 | EP1397132A4 Pirenzepine ophthalmic gel |
| 12/13/2006 | EP1383765B1 Carboline derivatives as inhibitors of phosphodiesterase 5 (PDE5) for the treatment of cardiovascular diseases and erectile dysfunction |
| 12/13/2006 | EP1294823B1 Double-spiro organic compounds and electroluminescent devices |
| 12/13/2006 | EP1148880B1 Methods for restoring and/or enhancing accommodation in pseudo phakia |
| 12/13/2006 | CN1878773A Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands |
| 12/13/2006 | CN1878771A Substituted bicyclic quinazolin-4-ylamine derivatives |
| 12/13/2006 | CN1878767A Azole-based kinase inhibitors |
| 12/13/2006 | CN1878759A Pyridazin-3 (2H) -one derivatives and their use as PDE4 inhibitors |
| 12/13/2006 | CN1876653A Zolpidem hemitartrate |
| 12/13/2006 | CN1876652A Zolpidem hemitartrate |
| 12/13/2006 | CN1289501C Fused heterotricyclic compound, process for preparing compounds and drugs containing the same |
| 12/13/2006 | CN1289500C Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 12/13/2006 | CN1289499C Pirazino (aza) indole derivatives |
| 12/13/2006 | CN1289466C Pharmaceutical compounds |
| 12/12/2006 | US7148353 For therapy of anxiety and insomnia |
| 12/12/2006 | US7148351 Antiscaling agents |
| 12/12/2006 | US7148240 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 12/12/2006 | US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity |
| 12/12/2006 | US7148235 Heterocyclic amines such as 3-[2-(4-(1H-indol-3-yl)-3,6-dihydro-1(2H)-pyridinyl)ethyl]-6-7-dimethoxy-4(3H)-quinazolinone, used as antidepressants or anxiolytic agents for prophylaxis of psychological disorders |
| 12/12/2006 | US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 12/12/2006 | US7148226 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 12/12/2006 | US7148224 Pyrazinone derivatives |
| 12/12/2006 | US7148222 Substituted pyrido-pyridazine derivatives which enhance cognition via the GABA-A receptors |
| 12/12/2006 | US7148214 Antihistaminic spiro compounds |
| 12/12/2006 | CA2201435C Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2a]indol - carbocylic acids and their activated derivatives |
| 12/12/2006 | CA2147608C Topoisomerase ii inhibitors and therapeutic uses therefor |
| 12/07/2006 | WO2006130852A1 Recovery of clopidogrel bisulfate |
| 12/07/2006 | WO2006130673A1 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 12/07/2006 | WO2006129826A1 Novel piperidine derivative |
| 12/07/2006 | WO2006129679A1 Spiropiperidine compound and medicinal use thereof |
| 12/07/2006 | WO2006129432A1 Carboxamide compound and use thereof |
| 12/07/2006 | WO2006129120A2 Benzotriazepinone derivatives |
| 12/07/2006 | WO2006128920A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation |
| 12/07/2006 | WO2006128853A1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 12/07/2006 | WO2006128852A2 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 12/07/2006 | WO2006128851A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors |
| 12/07/2006 | WO2006128791A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation |
| 12/07/2006 | WO2006128692A2 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
| 12/07/2006 | WO2006095234A3 Integrin targeted synthetic ligands for diagnostic and therapeutic applications |
| 12/07/2006 | WO2006075094A3 Purine derivatives compositions containing the same and use thereof against cancer |
| 12/07/2006 | WO2006068796A3 Inhibitors of akt activity |
| 12/07/2006 | US20060276652 Preparation of tadalafil intermediates |
| 12/07/2006 | US20060276646 MAP kinase inhibitors; treating arthritis, ankylosing spondylitis, psoriatic arthritis, various gastrointestinal disorders; adult respiratory distress syndrome, asthma, COPD and Alzheimer's disease. |
| 12/07/2006 | US20060276642 Compounds to treat Alzheimer's disease |
| 12/07/2006 | US20060276499 Imidazopyridine intermediates |
| 12/07/2006 | US20060276498 4,6-diamino-[1,7]naphthyridine-3-carbonitrile inhibitors of Tpl2 kinase and methods of making and using the same |
| 12/07/2006 | US20060276497 Novel multicyclic compounds and the use thereof |
| 12/07/2006 | US20060276496 Anti-Cytokine Heterocyclic Compounds |
| 12/07/2006 | US20060276487 New compounds useful for DPP-IV enzyme inhibition |
| 12/07/2006 | US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid |